Conference Coverage

PSYCHIATRY UPDATE 2016


 

Mild Cognitive Impairment: “Senior Moments” and DSM-5
George T. Grossberg, MD, Saint Louis University

Subjective cognitive impairment (SCI) is a prodrome to mild cognitive impairment (MCI), which is a prodrome to Alzheimer’s disease (AD), although not all patients with MCI convert to AD. Taking a thorough history with the patient and family is the most important part of the dementia workup, which also includes a thorough physical and neurologic exam and neuropsychological assessment. Earliest recognition is possible with biomarkers, but their use is not practical in clinical practice. Depression and anxiety can mimic SCI, which points to the importance of assessing for psychiatric illness. There are no FDA-approved treatments for SCI or MCI, but diet and lifestyle modifications can slow progression.

Pages

Recommended Reading

FDA announces new plan to combat opioid abuse
MDedge Psychiatry
NIDA releases strategic plan to prevent, treat substance use disorders
MDedge Psychiatry
ThriveNYC could help treat and destigmatize mental, behavioral disorders
MDedge Psychiatry
Designer drug symptoms can mimic schizophrenia, anxiety, depression
MDedge Psychiatry
Opioid prescribing: An odyssey of challenges
MDedge Psychiatry
Opiate drug detox appears safe in pregnancy
MDedge Psychiatry
Pot tied to increased risk of substance use disorders, not depression or anxiety
MDedge Psychiatry
We are not ‘psychiatrists’; 'The beauty of the asylum’; Challenges with false-positive urine drug screens
MDedge Psychiatry
Marijuana tourists also visiting Colorado EDs
MDedge Psychiatry
VIDEO: How proposed patient substance use privacy rule impacts physicians
MDedge Psychiatry